Overview

Gender

male

Investor Type

Investment Partner

Dr. Hiromichi Kimura is the founder, CEO, and a Managing Partner of FTI and a recognized leader in the Japanese biotech and pharmaceutical industry. With years of industry experience in top management, he has implemented numerous external collaborations and innovations. In addition to his career in venture capital, he directs academic studies in the field of innovation management and lifestyle design and biotechnology incubations with the Kawasaki city local government.

After Hiromichi’s successful career at Kyowa Hakko Kogyo (presently known as Kyowa Kirin) in its clinical research division and at JP Morgan in Financial Advisory and M&A, he joined Pharmacia (formerly known as Amersham Pharmacia Biotech before being acquired by GE Healthcare) where he eventually became the President and Representative Director. He was also the President and Representative Director of Monsanto Japan (currently Pfizer Japan) and served as the CEO of HuBit Genomix. Hiromichi has held academia positions as professor at the University of Tokyo and is currently a Project Professor at the University of Tokyo Institute for Future Initiatives (IFI). He is also the Deputy Chairman at Stanford Alumni Association Japan.